Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06402968 · ClinicalTrials.gov registry record
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
A clinical trial of Hypertension and Stroke, sponsored by Zeenat Qureshi Stroke Institute.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 9
- Study locations
NCT06402968: Recruiting study of Hypertension and Stroke, sponsored by Zeenat Qureshi Stroke Institute.
NCT06402968 is a study of Hypertension and Stroke that is actively recruiting participants, run by Zeenat Qureshi Stroke Institute. The registered enrollment target is 1,000 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06402968, a study of Hypertension and Stroke, is actively recruiting participants, sponsored by Zeenat Qureshi Stroke Institute.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 9
- Study locations
Study Summary
The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.
Conditions Studied
Interventions
- DRUG Clevidipine Injection
- DRUG Alternate IV Antihypertensive Regimen
Study Locations (9)
Texas
- UT Southwestern Medical Center - Dallas
- University of Texas Health Science Center San Antonio - San Antonio
California
- Antelope Valley Medical Center - Lancaster
Florida
- Cleveland Clinic Martin North Hospital - Stuart
Georgia
- Augusta University-Neuroscience Center - Augusta
Michigan
- University of Michigan Health-West - Wyoming
Missouri
- University of Missouri - Columbia
New York
- Icahn School of Medicine at Mount Sinai - New York
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2028-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06402968
The ClinicalTrials.gov registry entry for NCT06402968 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (71% lower). The listed sponsor is Zeenat Qureshi Stroke Institute, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Clevidipine Injection is the first listed.
NCT06402968 reports 9 study locations spanning 8 distinct geographic areas - top geographies include Texas, California, Florida.
Frequently Asked Questions
What is clinical trial NCT06402968 about?
NCT06402968 is a clinical study titled "Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage". The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.
What is the current status of trial NCT06402968?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2024-06-01. Estimated completion is 2028-07-30.
What conditions does trial NCT06402968 study?
This clinical trial studies the following conditions: Hypertension, Stroke, Intracerebral Hemorrhage.
What interventions are being tested in trial NCT06402968?
The interventions under investigation include: Clevidipine Injection (DRUG), Alternate IV Antihypertensive Regimen (DRUG).
Who is sponsoring clinical trial NCT06402968?
This trial is sponsored by Zeenat Qureshi Stroke Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06402968 being conducted?
This trial has 9 study locations across California, Florida, Georgia, Michigan, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Childhood-Onset Essential Hypertension Natural History Study
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.